Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

45.91
Delayed Data
As of Oct 23
 -0.89 / -1.90%
Today’s Change
25.97
Today|||52-Week Range
60.98
-8.38%
Year-to-Date

Today’s Trading

Previous close46.80
Today’s open46.52
Day’s range45.77 - 46.70
Volume209,373
Average volume (3 months)309,604
Market cap$1.4B
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)-126.44%
Earnings growth (this year)-118.37%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.92%
P/E ratioNM
Price/Sales44.01
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.25-1.03%
EDITEditas Medicine Inc-0.14-0.58%
MYOVMyovant Sciences Ltd+0.08+0.58%
EPZMEpizyme Inc-0.55-3.23%
Data as of 10/23/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$30.7M
Annual profit (last year)-$65.7M
Net profit margin-214.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Operating Officer &
Director
Aron M. Knickerbocker
Corporate headquarters
South San Francisco, California

Forecasts